Category Diabetes & Endocrinology

(Reuters) – Americans are still eagerly seeking prescriptions for Eli Lilly and Novo Nordisk’s weight-loss and diabetes drugs but cannot always fill them because of supply issues and insurance hurdles, according to their doctors. Those frustrations, along with the medicines’…